Superworth

Mimedx PE ratio MDXG

Share price divided by earnings per share over the last twelve months, since 2015.

Today, Nov 2, 2026
n/m
losses over the last year
Last meaningful
97.8×
Oct 2026
10-year median
21.0×
10-year range
3.7× to 119×
Peer median
21.3×

Mimedx has no meaningful PE ratio today: it lost $0.13 a share over the last twelve months, and a PE needs earnings.

It was last meaningful in Oct 2026, at 97.8×.

On the days it had one over the last ten years, its median was 21.0×, from 3.7× in Dec 2018 to 119× in Sep 2026.

PE ratio over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far97.8×10.7×119×
202525.6×16.6×34.8×
202419.6×9.1×22.1×
2023n/m a value too high to mean anything
2022n/m a value too high to mean anything
2021n/m a value too high to mean anything
202016.6×16.6×24.3×
201923.4×6.6×23.9×
20184.8×3.7×55.5×
201740.7×35.8×115×
201652.1×27.3×58.6×
201552.1×43.1×218×

Against its peers

Companies in Medical - Instruments & Supplies nearest Mimedx's size, closest first, today.

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Mimedx

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.